IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

MPM Asset Management LLC

Q1 2025 Holdings

Filed 2025-05-15 | 6 holdings | $69.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Entrada Therapeutics, Inc.(TRDA)Common29384C108$39.6M4,381,06257.0%
iTeos Therapeutics, Inc.(5E7)Common46565G104$16.4M2,738,78523.5%
Dyne Therapeutics, Inc.(DYN)Common26818M108$7.1M682,37610.3%
Werewolf Therapeutics, Inc.(HOWL)Common95075A107$4.2M4,309,8606.0%
Repare Therapeutics, Inc.(RPTX)Common760273102$1.1M1,121,3181.6%
Adaptimmune Therapeutics plc(ADAPY)Sponsored ADR00653A107$1.1M5,335,7151.5%